Evaluation of bivalirudin-based anticoagulation for extracorporeal membrane oxygenation, including patients with COVID-19

Background: Although unfractionated heparin (UFH) has traditionally been used for anticoagulation during extracorporeal membrane oxygenation (ECMO), bivalirudin may be preferred due to fewer complications. A prior medication use evaluation of ECMO patients who received bivalirudin resulted in dosing...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Raguindin Miranda, Bardsley Casey, Bast Chelsea, Sugrue David, Kazmi Hasan, Milkovits Ashley
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	EDP Sciences 2026-03-01
Saila:	The Journal of ExtraCorporeal Technology
Gaiak:	ecmo (extracorporeal membrane oxygenation) bivalirudin pharmacology acute respiratory distress syndrome (ards) covid-19
Sarrera elektronikoa:	https://ject.edpsciences.org/articles/ject/full_html/2026/01/ject250056/ject250056.html
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!